Saama Appoints Neelesh Sali to Head, Europe & APAC and Managing Director, India

0
215






Campbell, Calif., United States:
 

Saama as we speak introduced that Neelesh Sali has joined the corporate as Head, Europe & APAC and Managing Director, India.


 

In his new position, Neelesh can be chargeable for overseeing all points of Saama’s business in Europe and APAC and handle its operations in India.


 

“Neelesh is a proven leader with a track record of success in delivering growth and operational excellence,” stated Vivek Sharma, Chief Executive Officer of Saama Technologies. “His appointment reflects our commitment to further strengthen our presence in Europe, APAC, and India and serve customers and patients, and we are confident that he will be a valuable asset in helping us achieve our long-term goals.”


 

Neelesh Sali brings 30 years of expertise to his new position at Saama. Most just lately, he served as Head of Global Delivery Centre, Science Group at Clarivate Analytics and Managing Director of DRG India.


 

Neelesh has vital expertise in heading up and scaling giant analytics operations. In his earlier position as Head of Global Delivery Centre, Science Group at Clarivate Analytics, he was chargeable for managing the corporate’s Global Delivery Centre. As Managing Director of DRG India, he contributed to delivering the corporate’s highest annual income development in 2019.


 

Prior to that, he was Vice President and Service Line Leader at Genpact, and delivered robust income development for the business in 2017 and 2018.


 

About Saama


 

Saama develops life science options that speed up scientific and business growth. Today, greater than 50 biotech corporations—together with most of the prime 20 pharmaceutical corporations—use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform to speed up greater than 1,500 research, together with the scientific trial that led to the world’s first COVID-19 vaccine. LSAC’s wealthy functions facilitate unprecedented and authoritative oversight and automation of complete scientific analysis information, enabling corporations to file New Drug Applications (NDAs) extra effectively and carry therapies to sufferers sooner. Discover extra at www.saama.com and observe @SaamaTechInc on Twitter.


 


 







Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here